ANDA.JPG

Office of Generic Drugs (OGD) providing update to improve transparency related to Generic Drug User Fee Amendments of 2012 (GDUFA)

  • proportion of pending ANDA workload
  • proportion of ANDA workload pending response by industry
  • ongoing review communications between FDA and industry

LEARN

Image credit: FDA

Published by Drug & Device Advisory Group


Leave a Reply


Fill in your details below or click an icon to log in:

Gravatar

WordPress.com Logo



You are commenting using your WordPress.com account.
( Log Out / 
Change )

Google photo



You are commenting using your Google account.
( Log Out / 
Change )

Twitter picture



You are commenting using your Twitter account.
( Log Out / 
Change )

Facebook photo



You are commenting using your Facebook account.
( Log Out / 
Change )

Cancel

Connecting to %s